03/29/2024
5:11 AM | Cyteir Therapeutics (Filer)
| Form 15-12G | |
03/25/2024
10:05 AM | Cyteir Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:16 PM | Cyteir Therapeutics (Filer)
| Form S-8 POS | |
03/21/2024
3:17 PM | Cyteir Therapeutics (Filer)
| Form S-8 POS | |
03/21/2024
3:17 PM | Cyteir Therapeutics (Filer)
| Form S-8 POS | |
03/20/2024
3:55 PM | Cyteir Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
6:21 AM | Cyteir Therapeutics (Filer)
| Form POS AM | |
|
03/18/2024
6:23 AM | Cyteir Therapeutics (Filer)
| Form POS AM | |
03/18/2024
6:24 AM | Cyteir Therapeutics (Filer)
| Form POS AM | |
03/18/2024
5:07 AM | Cyteir Therapeutics (Filer)
| Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities | |
03/13/2024
11:15 PM | Cyteir Therapeutics (Filer)
| Form EFFECT | |
03/12/2024
3:30 PM | Cyteir Therapeutics (Filer)
| Form POS AM | |
03/12/2024
3:16 PM | Cyteir Therapeutics (Subject)
GAMCO INVESTORS, INC. ET AL (Filed by)
| Form SC 13D/A | |
03/07/2024
3:31 PM | Cyteir Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
5:10 PM | Cyteir Therapeutics (Issuer)
RENSCHLER MARKUS MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
5:11 PM | Cyteir Therapeutics (Issuer)
Gaiero David G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:36 PM | Cyteir Therapeutics (Subject)
Lightstone Ventures II, L.P. (Filed by)
| Form SC 13G/A | |
02/13/2024
6:14 PM | Avidity Partners Management LP (Filed by)
Cyteir Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
3:28 PM | Cyteir Therapeutics (Subject)
GAMCO INVESTORS, INC. ET AL (Filed by)
| Form SC 13D/A | |
02/08/2024
3:11 PM | Cyteir Therapeutics (Issuer)
Zakrzewski Joseph S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
12:40 PM | BML Investment Partners, L.P. (Filed by)
Cyteir Therapeutics (Subject)
| Form SC 13G/A | |
01/19/2024
8:30 AM | Cyteir Therapeutics (Subject)
HEDGEHOG CAPITAL LLC (Filed by)
| Form SC 13G/A | |
11/22/2023
12:47 PM | Cyteir Therapeutics (Issuer)
Gaiero David G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
12:48 PM | Cyteir Therapeutics (Issuer)
RENSCHLER MARKUS MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
4:00 PM | Cyteir Therapeutics (Subject)
HEDGEHOG CAPITAL LLC (Filed by)
| Form SC 13G | |
10/19/2023
3:07 PM | Cyteir Therapeutics (Subject)
GAMCO INVESTORS, INC. ET AL (Filed by)
| Form SC 13D | |
10/12/2023
3:14 PM | Cyteir Therapeutics (Filer)
| Form DEFM14A | |
10/12/2023
6:51 AM | Cyteir Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
6:52 AM | Cyteir Therapeutics (Filer)
| Form DEFA14A | |
10/02/2023
3:44 PM | Cyteir Therapeutics (Filer)
| Form PREM14A | |
07/20/2023
7:01 PM | Cyteir Therapeutics (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
7:27 PM | Cyteir Therapeutics (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2023
3:56 PM | Cyteir Therapeutics (Subject)
Novo Holdings A/S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023
9:20 AM | Cyteir Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
07/03/2023
5:29 PM | Cyteir Therapeutics (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
4:29 PM | Cyteir Therapeutics (Subject)
Secrist John Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023
9:37 AM | Cyteir Therapeutics (Filer)
| Form DEFA14A | |
06/30/2023
9:22 AM | Cyteir Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
8:35 PM | Cyteir Therapeutics (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
5:02 PM | Cyteir Therapeutics (Subject)
Secrist John Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2023
6:17 PM | Cyteir Therapeutics (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
It’s now possible to know the win rate of every trade… BEFORE you take it! (Ad) Would you like to know the historic win rate of every trade you take before you place it?
Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.
 >> You can grab your FREE, laminated copies right here << |
06/20/2023
4:53 PM | Cyteir Therapeutics (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
7:18 PM | Cyteir Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
7:18 PM | Cyteir Therapeutics (Issuer)
Novo Holdings A/S (Reporting)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
7:14 PM | Cyteir Therapeutics (Subject)
Novo Holdings A/S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
7:00 AM | Cyteir Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2023
3:27 PM | Cyteir Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
3:07 PM | Cyteir Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
